Peter M. Mourani, MD, has been named Medical Director for the Children’s Clinical Research Organization (CCRO). In this role, he will be the overall medical leader for the CCRO and will work in close collaboration with investigators, leaders and staff across the organization and campus to improve, expand and oversee research services, regulatory compliance, and operations at CHCO.
Dr. Mourani is an Associate Professor of Pediatrics and Director of Clinical Research in the Section of Critical Care Medicine at the University of Colorado School of Medicine and Children’s Hospital Colorado, and he has been serving as the Associate Director of the CCRO for the past three years. During his time with the CCRO, Dr. Mourani has had direct responsibility for operations of the centralized clinical research infrastructure at CHCO, including oversight of study feasibility, implementation, regulatory adherence, monitoring, project management, research coordination, and budgeting for NIH, non-profit, and industry sponsored clinical trials.
Dr. Mourani obtained his medical degree and performed his pediatric residency at Loyola University Medical Center in Maywood, IL. He completed a combined fellowship in Pediatric Critical Care and Pulmonary Medicine at the University of Colorado School of Medicine in 2001. Under the mentorship of Kurt Stenmark, MD, and Steven Abman, MD, Dr. Mourani has conducted clinical and translational research studies investigating the mechanisms of bronchopulmonary dysplasia and pulmonary hypertension in preterm infants and exploring the microbiology of ventilator associated pneumonia. He was recently awarded an R01 to study the role of the airway microbiome and host immune responses in ventilator-associated pneumonia and has been selected to lead our site in the NIH U01-funded Collaborative Pediatric Critical Care Research Network (CPCCRN).
Lalit Bajaj, MD, MPH, who served as the Medical Director of the CCRO for the past three years, was appointed to the position of Medical Director of the Center for Clinical Effectiveness. Dr. Bajaj has led the effort in the transformation and growth of our clinical research services enterprise over the past three years. Under his leadership, the CCRO has achieved many significant accomplishments, including a reorganization of the research start-up process, creation of numerous standard operating procedures to safely and efficiently conduct clinical research, development of processes for improved financial management of clinical research projects, and engagement and support of numerous investigators in the execution of their research projects. Given the natural overlap between clinical research and clinical effectiveness, Lalit will continue to serve as a Senior Advisor/Associate Director to the CCRO to enhance the integration and collaboration of these two important groups.